99mTc-EDDA/HYNIC-octreotate scintigraphy, an efficient method for the detection and staging of carcinoid tumours: results of 3 years’ experience

[1]  B. Eriksson,et al.  Nuclear medicine in the detection, staging and treatment of gastrointestinal carcinoid tumours. , 2005, Best practice & research. Clinical endocrinology & metabolism.

[2]  R. Sutton,et al.  Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours , 2005, Gut.

[3]  J. Soga.  Early‐stage carcinoids of the gastrointestinal tract , 2005, Cancer.

[4]  B. Taal,et al.  Metastatic carcinoid tumors: a clinical review. , 2005, The oncologist.

[5]  H. Amthauer,et al.  Diagnosis of neuroendocrine tumours by retrospective image fusion: is there a benefit? , 2004, European Journal of Nuclear Medicine and Molecular Imaging.

[6]  A. Tarkowska,et al.  Diagnosis and staging of children’s lymphoma using the technetium-labelled somatostatin analogue, 99mTc-depreotide , 2004, European Journal of Nuclear Medicine and Molecular Imaging.

[7]  R. Mikołajczak,et al.  Clinical usefulness of 99mTc-EDDA/HYNIC-TOC scintigraphy in oncological diagnostics: a preliminary communication , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[8]  R. Moncayo,et al.  99mTc-Demotate 1: first data in tumour patients—results of a pilot/phase I study , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[9]  Francesco Scopinaro,et al.  Somatostatin receptor scintigraphy in liver metastasis detection from gastroenteropancreatic neuroendocrine tumors. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[10]  P. Angelberger,et al.  Effects of chemotherapeutic agents on expression of somatostatin receptors in pancreatic tumor cells. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[11]  P. Schöffski,et al.  Biokinetics and imaging with the somatostatin receptor PET radioligand 68Ga-DOTATOC: preliminary data , 2001, European Journal of Nuclear Medicine.

[12]  Eva Forssell-Aronsson,et al.  Intraoperative tumour detection using 111In-DTPA-D-Phe1-octreotide and a scintillation detector , 2001, European Journal of Nuclear Medicine.

[13]  E. Krenning,et al.  [177Lu-DOTA0,Tyr3]octreotate: comparison with [111In-DTPA0]octreotide in patients , 2001, European Journal of Nuclear Medicine.

[14]  F. Orsi,et al.  Receptor-mediated radiotherapy with 90Y-DOTA-D-Phe1-Tyr3-octreotide , 2001, European Journal of Nuclear Medicine.

[15]  R. Moncayo,et al.  99mTc-EDDA/HYNIC-TOC: a new 99mTc-labelled radiopharmaceutical for imaging somatostatin receptor-positive tumours: first clinical results and intra-patient comparison with 111In-labelled octreotide derivatives , 2000, European Journal of Nuclear Medicine.

[16]  M. Béhé,et al.  Detection of somatostatin receptor-positive tumours using the new 99mTc-tricine-HYNIC-d-Phe1-Tyr3-octreotide: first results in patients and comparison with 111In-DTPA-d-Phe1-octreotide , 2000, European Journal of Nuclear Medicine.

[17]  J. Blum,et al.  A multicenter trial with a somatostatin analog (99m)Tc depreotide in the evaluation of solitary pulmonary nodules. , 2000, Chest.

[18]  J. Reubi,et al.  Affinity profiles for human somatostatin receptor subtypes SST1–SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use , 2000, European Journal of Nuclear Medicine.

[19]  R. Baum,et al.  Intraoperative use of gamma-detecting probes to localize neuroendocrine tumors. , 2000, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology.

[20]  S. Mather,et al.  Technetium-99m somatostatin analogues: effect of labelling methods and peptide sequence , 1999, European Journal of Nuclear Medicine.

[21]  Y. Patel.  Somatostatin and Its Receptor Family , 1999, Frontiers in Neuroendocrinology.

[22]  S. Fanti,et al.  Comparison of somatostatin receptor imaging, computed tomography and ultrasound in the clinical management of neuroendocrine gastro-entero-pancreatic tumours , 1998, European Journal of Nuclear Medicine.

[23]  P. Valent,et al.  Tc-p829 99m of a Novel Tumor Tracer, Binding in Vivo Somatostatin Receptor Subtype Specificity and Updated Version Citing Articles E-mail Alerts Somatostatin Receptor Subtype Specificity and in Vivo Binding of a Novel Tumor Tracer, 99mtc-p8291 , 2013 .

[24]  J. Crothers,et al.  Localization of neuroendocrine tumours with [111In] DTPA-octreotide scintigraphy (Octreoscan): a comparative study with CT and MR imaging. , 1998, QJM : monthly journal of the Association of Physicians.

[25]  J. Barrett,et al.  99mTc labeling of highly potent small peptides. , 1997, Bioconjugate chemistry.

[26]  A. Fischman,et al.  Technetium-99m-labeled hydrazino nicotinamide derivatized chemotactic peptide analogs for imaging focal sites of bacterial infection. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[27]  E. P. Krenning,et al.  Somatostatin receptor scintigraphy with [111In-DTPA-d-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients , 1993, European Journal of Nuclear Medicine.

[28]  E. Krenning,et al.  Somatostatin analogue scintigraphy in carcinoid tumours , 1993, European Journal of Nuclear Medicine.

[29]  R. Weller,et al.  International Histological Classification of Tumours , 1981 .

[30]  Uwe Haberkorn,et al.  Evaluation of positron emission tomography imaging using [68Ga]-DOTA-D Phe(1)-Tyr(3)-Octreotide in comparison to [111In]-DTPAOC SPECT. First results in patients with neuroendocrine tumors. , 2003, Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging.

[31]  L. Sobin,et al.  Histological Typing of Endocrine Tumours , 2000, International Histological Classification of Tumours.

[32]  S. Kuwada.  Carcinoid tumors. , 2000, Seminars in gastrointestinal disease.

[33]  A. Burroughs,et al.  Carcinoid tumour. , 1998, Lancet.

[34]  A. Bornstein,et al.  Carcinoid Tumors , 2006 .